Skip to content

G8, VES-13 and CARG Scores in Predicting Chemotherapy Toxicity in Geriatric Cancer Patients

The Predictive Value of G8, VES-13 and CARG Scores in Treatment-related Toxicity in Geriatric Cancer Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04992455
Enrollment
150
Registered
2021-08-05
Start date
2021-02-01
Completion date
2021-09-01
Last updated
2021-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Predicting Chemotherapy Related Toxicity in Elderly Patients

Keywords

g8, ves-13, CARG, chemotherapy-related toxicity, Toxicity tool

Brief summary

All participants' medical information will be collected for use as a baseline, including tumor-specific variables, nutritional status, functional status, psychological status, cognitive function, social support, and comorbidities. The suitability of G8, VES-13 and CARG chemotherapy risk assessment tools for elderly cancer patients was investigated.

Detailed description

All participants' medical information will be collected for use as a baseline, including tumor-specific variables, nutritional status, functional status, psychological status, cognitive function, social support, and comorbidities. G8, VES-13 and CARG toxicity scores of all participating patients will be determined by two independent investigators before starting chemotherapy. The suitability of these practical chemotherapy risk assessment tools for cancer patients for elderly cancer patients was investigated.

Interventions

OTHEROlder Patients Receiving Chemotherapy

No Intervention

Sponsors

Namik Kemal University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged ≥65 years * Localized or metastatic solid carcinoma diagnosed by histology (any type, any stage) * Starting a new-line (first-line, second-line or third-line) chemotherapy

Exclusion criteria

* Concurrent radiotherapy; * Simultaneous immunotherapy * Impaired language * Cognitive function leading to inability to complete assessments.

Design outcomes

Primary

MeasureTime frame
G8 (Geriatric 8) screening tool measurement15-30 minutes
CARG (Cancer and Aging Research Group) chemotherapy toxicity score measurement30-60 minutes
VES-13 (Vulnerable Elders Survey-13) measurement30-60 minutes

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026